Outputs (14)

Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. (2018)
Journal Article
JASSIM, Z., ELAJEZ, R., KHUDAIR, I., AL ANANY, R., AL-ADAWI, R.M. 2019. Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. Journal of pharmaceutical health services research [online], 10(1), pages 73-80. Available from: https://doi.org/10.1111/jphs.12240

Objective: Compare efficacy and safety of liraglutide (1.8 mg subcutaneous once daily) and exenatide (10 mcg subcutaneous twice daily) in uncontrolled type 2 diabetes at 26 and 52 weeks. Method: A retrospective observation study of uncontrolled type... Read More about Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study..

The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol] (2018)
Other
AL ADAWI, R., TONNA, A., STEWERT, D., RAYAN, C., ELEDRISI, M., and ABDELAZIZ, H. [2018]. The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol]. PROSPERO [online], item number CRD42018089862. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018089862

The aim of this research was to critically appraise, synthesise, and present the available evidence on the impact of pharmacists' input on the screening, prevention and management of metabolic syndrome (MetS). The specific aims were: 1) To determine... Read More about The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol].

Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital. (2016)
Presentation / Conference
JASSIM, Z., MOUSTAFA, R. and AZIZ, H.A. 2016. Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital. Presented at 2016 Qatar Foundation annual research conference (ARC 16), 22-23 March 2016, Doha, Qatar.

Objective: The primary purpose of this research is to evaluate the risk of hyperkalemia in patients receiving co-trimoxazole. The secondary purpose is to detect the changes of potassium levels from baseline to 7, 14, 21, and 30 days, determine the as... Read More about Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital..

Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis. (2016)
Presentation / Conference
MOUSTAFA, R., JASSIM, Z., AZIZ, H.A., KHUDAIR, I. and SALEM, M. 2016. Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis. Presented at 2016 Qatar Foundation annual research conference (ARC 16), 22-23 March 2016, Doha, Qatar.

Objective: This study aimed to assess the adherence and persistence to Calcium and vitamin D, and address the reasons of non-adherence. Methods: All patients attending a secondary care rheumatology clinic in a teaching hospital serving a multiethnic... Read More about Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis..